Ajooni Biotech Ltd Stock Price Today (NSE: AJOONI)
Fundamental Score
Ajooni Biotech Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Ajooni Biotech Ltd share price today is ₹4.99, up +0.00% on NSE/BSE as of 17 February 2026. Ajooni Biotech Ltd (AJOONI) is a Small-cap company in the Animal Feed sector with a market capitalisation of ₹81.64 (Cr). The 52-week high for AJOONI share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 20.51x, AJOONI is currently trading above its industry average P/E of 18.96x. The company has a Return on Equity (ROE) of 5.15% and a debt-to-equity ratio of 0.10.
Ajooni Biotech Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Ajooni Biotech Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Ajooni Biotech Share Price: A Financial Analysis
The animal feed industry, experiencing a global push for sustainable and traceable sourcing, faces a complex landscape of fluctuating raw material costs and evolving consumer preferences. This analysis delves into the financial standing of Ajooni Biotech, focusing on its current market valuation. The current Ajooni Biotech share price is ₹4.949999809265137, with a Price-to-Earnings (PE) ratio of 20.51. This valuation needs careful consideration in light of the company's profitability and competitive positioning within the sector. This analysis is part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra.
Ajooni Biotech's Return on Capital Employed (ROCE) currently stands at 6.91%. ROCE is a critical metric as it reflects how effectively the company is generating profits from its invested capital. A lower ROCE, compared to industry benchmarks, may indicate less efficient capital utilization. This impacts the company’s moat – its ability to maintain a competitive advantage and protect its market share. A higher ROCE generally suggests a stronger moat, allowing the company to reinvest profits and compound growth more effectively.
Comparing Ajooni Biotech with its peers offers further insights. For example,
Avanti Feeds Ltd, a more established player, may exhibit different characteristics in terms of management quality, capital allocation decisions, and operational efficiency. These factors can ultimately translate into differing levels of shareholder value creation. While we're not making a statement about management directly, it's commonly observed that superior management teams often drive higher ROCE figures and more sustainable growth.Further examination of Ajooni Biotech’s financial statements, including its debt levels, revenue growth, and operating margins, is necessary to form a comprehensive understanding of its long-term financial health. The current PE ratio of 20.51, juxtaposed with the ROCE of 6.91%, warrants a deeper investigation into the company's earnings sustainability and growth prospects. A thorough understanding of these key performance indicators is essential for informed analysis.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Ajooni Biotech Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AJOONI across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Robust Profit Growth (50.00%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (23.41%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (23.40% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (57.50% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (55.56% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.10)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (14.63x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
6 factors identified
Below-Average Return on Equity (5.15%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (6.91%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (3.40%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Negative Free Cash Flow (₹-10.62 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (26.89%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Ajooni Biotech Ltd Financial Statements
Comprehensive financial data for Ajooni Biotech Ltd including income statement, balance sheet and cash flow
About AJOONI (Ajooni Biotech Ltd)
Ajooni Biotech Ltd (AJOONI) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Animal Feed sector with a current market capitalisation of ₹81.64 (Cr). Ajooni Biotech Ltd has delivered a Return on Equity (ROE) of 5.15% and a ROCE of 6.91%. The debt-to-equity ratio stands at 0.10, reflecting the company's capital structure. Investors tracking AJOONI share price can monitor key metrics including P/E ratio, promoter holding of 26.89%, and quarterly earnings growth.
Company Details
Key Leadership
AJOONI Share Price: Frequently Asked Questions
What is the current share price of Ajooni Biotech Ltd (AJOONI)?
As of 17 Feb 2026, 10:07 am IST, Ajooni Biotech Ltd share price is ₹4.99. The AJOONI stock has a market capitalisation of ₹81.64 (Cr) on NSE/BSE.
Is AJOONI share price Overvalued or Undervalued?
AJOONI share price is currently trading at a P/E ratio of 20.51x, compared to the industry average of 18.96x. Based on this relative valuation, the Ajooni Biotech Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of AJOONI share price?
The 52-week high of AJOONI share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Ajooni Biotech Ltd share price?
Key factors influencing AJOONI share price include quarterly earnings growth (Sales Growth: 23.41%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Ajooni Biotech Ltd a good stock for long-term investment?
Ajooni Biotech Ltd shows a 5-year Profit Growth of 55.56% and an ROE of 5.15%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.10 before investing in AJOONI shares.
How does Ajooni Biotech Ltd compare with its industry peers?
Ajooni Biotech Ltd competes with major peers in the Animal Feed. Investors should compare AJOONI share price P/E of 20.51x and ROE of 5.15% against the industry averages to determine competitive standing.
What is the P/E ratio of AJOONI and what does it mean?
AJOONI share price has a P/E ratio of 20.51x compared to the industry average of 18.96x. Investors pay ₹21 for every ₹1 of annual earnings.
How is AJOONI performing according to Bull Run's analysis?
AJOONI has a Bull Run fundamental score of 51.9/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does AJOONI belong to?
AJOONI operates in the Animal Feed industry. This classification helps understand the competitive landscape and sector-specific trends affecting Ajooni Biotech Ltd share price.
What is Return on Equity (ROE) and why is it important for AJOONI?
AJOONI has an ROE of 5.15%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Ajooni Biotech Ltd generates profits from shareholders capital.
How is AJOONI debt-to-equity ratio and what does it indicate?
AJOONI has a debt-to-equity ratio of 0.10, which indicates conservative financing with low financial risk.
What is AJOONI dividend yield and is it a good dividend stock?
AJOONI offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Ajooni Biotech Ltd shares.
How has AJOONI share price grown over the past 5 years?
AJOONI has achieved 5-year growth rates of: Sales Growth 23.40%, Profit Growth 55.56%, and EPS Growth 57.50%.
What is the promoter holding in AJOONI and why does it matter?
Promoters hold 26.89% of AJOONI shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Ajooni Biotech Ltd.
What is AJOONI market capitalisation category?
AJOONI has a market capitalisation of ₹82 crores, placing it in the Small-cap category.
How volatile is AJOONI stock?
AJOONI has a beta of N/A. A beta > 1 suggests the Ajooni Biotech Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is AJOONI operating profit margin trend?
AJOONI has a 5-year average Operating Profit Margin (OPM) of 3.40%, indicating the company's operational efficiency.
How is AJOONI quarterly performance?
Recent quarterly performance shows Ajooni Biotech Ltd YoY Sales Growth of 23.41% and YoY Profit Growth of 50.00%.
What is the institutional holding pattern in AJOONI?
AJOONI has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Ajooni Biotech Ltd stock.